The presentation by John Dahldorf, chief financial officer, will begin at 8 a.m., Eastern Daylight Time (5 a.m., Pacific Daylight Time).
The presentation will be available through the conference website at http://www.veracast.com/webcasts/twp/healthcare09/66101456.cfm and via the company's website at www.volcanocorp.com.
Volcano Corporation (NASDAQ: VOLC | Quote | Chart | News | PowerRating) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) and Forward-Looking IVUS systems and catheters. Currently, more than 4,000 Volcano IVUS and FM systems are installed worldwide, and more than half of Volcano's revenues are derived from outside the United States. Through its wholly-owned subsidiary, Axsun Technologies, Volcano also develops and manufactures optical monitors, lasers and optical engines used in telecommunications, spectroscopy and other industrial applications. These products are sold to a variety of customers, including Nokia Siemens Networks, Ericsson, Alcatel-Lucent and HuaWei Technologies. For more information, visit the company's website at http://www.volcanocorp.com.
SOURCE Volcano Corporation
http://www.volcanocorp.com

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index